Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2025-12-30 @ 4:13 AM
Study NCT ID:
NCT06041269
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-11-25
First Post:
2023-09-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)
Sponsor:
AnaptysBio, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-31
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-11
First Submit QC Date:
None
Study First Post Date:
2023-09-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-21
Last Update Post Date:
2024-11-25
Last Update Post Date Type:
ACTUAL